骨折后照护路径的微成本分析:来自国际骨质疏松性骨折成本与效用研究(ICUROS)的结果
该微成本分析纳入ICUROS中4126例≥50岁脆性骨折成人(髋部1657例、椎体681例、前臂远端1354例、肱骨434例),估算骨折后12个月不同健康相关生活质量轨迹对应的骨折部位特异性医疗服务路径成本。髋部、椎体、腕部、肱骨骨折每例患者总直接成本分别为89564、38926、18333、38461澳元(2021年澳元);20条照护路径中,与健康相关生活质量恢复相关的路径在各骨折部位每例患者平均成本较低。作者认为这些路径可能有助于医疗提供者更有效、更具成本效益地分配脆性骨折资源。
要点
- 髋部骨折每例总直接成本最高(89564澳元),腕部骨折最低(18333澳元)。
- 20条照护路径中,与健康相关生活质量恢复相关的路径在各骨折部位每例患者平均成本较低。
- 作者认为这些路径可能有助于更有效、更具成本效益地分配脆性骨折资源。
核心结论
- 本研究基于国际老年人群队列的医疗服务利用情况,识别了各骨折部位多种多学科照护路径的成本和健康相关生活质量影响。
- 作者认为这些照护路径可能有助于医疗提供者更有效、更具成本效益地分配脆性骨折资源。
研究设计与样本
- 微成本研究纳入ICUROS中4126例≥50岁脆性骨折成人,包括髋部1657例、椎体681例、前臂远端1354例、肱骨434例。
- ICUROS参与者在4个月和12个月随访访视时回顾其健康和社区照护服务使用的频率和持续时间(如适用)。
- 识别并汇总患者层面成本以确定每条照护路径中与骨折相关的医疗服务使用平均成本(以2021年澳元表示)。
- 计算平均成本差异并使用单因素方差分析(ANOVA)和事后Bonferroni校正分析以确定任何统计学显著差异。
主要发现
- 髋部、椎体、腕部和肱骨骨折每例患者总直接成本分别为89564、38926、18333和38461澳元。
- Kruskal-Wallis检验显示大多数照护路径之间成本值存在统计学显著差异(p < 0.001)。
- 20条照护路径中,与健康相关生活质量恢复相关的路径在各骨折部位每例患者平均成本较低。
关键数值与推荐
- 髋部骨折每例患者总直接成本为89564澳元(2021年澳元)。
- 椎体骨折每例患者总直接成本为38926澳元(2021年澳元)。
- 腕部骨折每例患者总直接成本为18333澳元(2021年澳元)。
- 肱骨骨折每例患者总直接成本为38461澳元(2021年澳元)。
- Kruskal-Wallis检验显示大多数照护路径之间成本值差异统计学显著(p < 0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This study identified the costs and health-related quality of life impacts of several post-fracture multidisciplinary care pathways specific to individual skeletal site (hip, distal forearm, vertebrae, humerus). These care pathways may assist healthcare providers in allocating resources for osteoporotic fractures in more effective and cost-efficient ways. INTRODUCTION: This micro-costing study was undertaken to provide the estimated healthcare costs of several fracture site-specific health service use pathways associated with different trajectories of health-related quality of life (HRQoL) 12-months post-fracture. METHODS: The study included 4126 adults aged ≥ 50 years with a fragility fracture (1657 hip, 681 vertebrae, 1354 distal forearm, 434 humerus) from the International Costs & Utilities Related to Osteoporotic fractures Study (ICUROS). ICUROS participants were asked to recall the frequency and duration (where applicable) of their health and community care service use at 4- and 12-month follow-up visits. Patient-level costs were identified and aggregated to determine the average cost of healthcare use related to the fracture in each care pathway (presented in Australian 2021 dollars). Mean cost differences were calculated and analysed using a one-way analysis of variance (ANOVA) and post hoc Bonferroni correction to determine any statistically significant differences. RESULTS: The total direct cost of fractures was estimated at $89564, $38926, $18333, and $38461AUD per patient for hip, vertebral, wrist, and humeral participants, respectively. A Kruskal-Wallis test yielded a statistically significant difference in cost values between most care pathways (p < 0.001). Of the 20 care pathways, those associated with recovery of HRQoL had lower mean costs per patient across each fracture site. CONCLUSIONS: This study identified the costs and HRQoL impacts of several multidisciplinary care pathways for individual fracture sites based on the health service utilization of an international cohort of older adults. These care pathways may assist healthcare providers in allocating resources for fragility fractures in more effective and cost-efficient ways.
引用
- Talevski J, Sanders KM, Lal A, et al. A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS). Osteoporos Int. 2022. PMID: 35701629. doi:10.1007/s00198-022-06460-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。